Literature DB >> 1684779

Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo.

R L Coffman1, K Varkila, P Scott, R Chatelain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1684779     DOI： 10.1111/j.1600-065x.1991.tb00611.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  60 in total

1.  Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.

Authors:  Anne-Sophie Beignon; Jean-Paul Briand; Sylviane Muller; Charalambos D Partidos
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.

Authors:  D F Hoft; C S Eickhoff
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.

Authors:  H Jiang; N S Braunstein; B Yu; R Winchester; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  Gamma interferon modifies CD4+ subset expression in murine candidiasis.

Authors:  L Romani; E Cenci; A Mencacci; R Spaccapelo; U Grohmann; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

Review 7.  Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

Authors:  N P Restifo; Y Kawakami; F Marincola; P Shamamian; A Taggarse; F Esquivel; S A Rosenberg
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-10

8.  Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Increased capacity for interleukin-2 synthesis parallels disease progression in mice infected with Leishmania major.

Authors:  F P Heinzel; R M Rerko; A M Hujer; R A Maier
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Gamma interferon is critical for resistance to Theiler's virus-induced demyelination.

Authors:  M Rodriguez; K Pavelko; R L Coffman
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.